Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracranial Ewing sarcoma.

Melissa A Mazur1, Sridharan Gururangan, Julia A Bridge

  • 1Department of Pediatric Hematology-Oncology, Duke University Medical Center, Durham, NC 27710, USA.

Pediatric Blood & Cancer
|June 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The history of medicine on postage stamps: Elizabeth Blackwell, "first woman physician".

The American journal of the medical sciences·2026
Same author

Hidradenoma in Axillary Lymph Nodes: A Diagnostic Pitfall Mimicking Metastatic Carcinoma.

The American journal of surgical pathology·2026
Same author

Autologous stem cell transplant for severe, progressive juvenile systemic sclerosis.

Stem cells translational medicine·2026
Same author

Factors Influencing Choice of Laboratory-Developed Tests and US Food and Drug Administration (FDA)-Approved or FDA-Cleared In Vitro Diagnostics for Molecular Analytes.

Archives of pathology & laboratory medicine·2026
Same author

Uterine teratomas: a report of clinicopathological features of five tumours.

Histopathology·2026
Same author

Management of Desmoid Tumors.

Current oncology reports·2025
Same journal

Comment on: "The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience"-The Evolving Role of the BIT Regimen.

Pediatric blood & cancer·2026
Same journal

Extramedullary Intradural Spinal Tumor in an Infant With Neurocutaneous Melanosis.

Pediatric blood & cancer·2026
Same journal

The Role of Hematopoietic Cell Transplantation in Ataxia-Telangiectasia.

Pediatric blood & cancer·2026
Same journal

Pediatric T-Lymphoblastic Lymphoma With T(9;17) and MIR142HG::NOTCH1 Fusion Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission.

Pediatric blood & cancer·2026
Same journal

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026
Same journal

Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026
See all related articles

Primary extraosseous Ewing sarcoma (EES) of the central nervous system (CNS) is rare but distinct from PNET. Molecular confirmation of EWS gene rearrangement is key for accurate diagnosis and treatment.

Area of Science:

  • Neuro-oncology
  • Molecular Pathology
  • Rare Cancers

Background:

  • Primary extraosseous Ewing sarcoma (EES) of the central nervous system (CNS) is exceptionally rare.
  • Distinguishing EES from central primitive neuroectodermal tumor (PNET) is critical due to differing treatment protocols.

Observation:

  • This study details two cases of primary CNS EES.
  • Tumors presented with clinical, radiologic, and pathologic features.
  • Diagnostic confirmation involved fluorescent in situ hybridization (FISH) to detect EWS gene rearrangements.

Findings:

  • FISH analysis confirmed EWS gene locus rearrangement in both patient tumors.
  • The specific translocation t(11;22)(q24;q12) was identified via molecular analysis.
  • EES should be considered in CNS tumors near the meningeal surface with PNET-like pathology.

Related Experiment Videos

Implications:

  • Accurate molecular diagnosis of EES is essential for appropriate oncologic management.
  • Early identification of EES can guide targeted therapy selection.
  • Increased awareness of CNS EES may improve diagnostic rates for this rare entity.